Treatment of patients (pts) with chemotherapy-refractory chronic lymphocytic leukemia (CLL) with nonmyeloablative (NM) conditioning and hematopoietic cell transplantation (HCT) from HLA-matched related (MRD) or unrelated donors (URD)

被引：2

作者：

Sorror, ML

Maris, MB

Sandmaier, BM

Jain-Stuart, M

Storer, B

Hegenbart, U

McSweeney, P

Chauncey, T

Bruno, B

Wade, J

Agura, E

Pulsipher, M

Leis, J

Little, MT

Niederwieser, D

Blume, K

Storb, R

Maloney, DG

机构：

[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[2] Univ Washington, Seattle, WA 98195 USA

[3] Seattle Vet Adm Med Ctr, Seattle, WA USA

[4] Stanford Univ, Palo Alto, CA 94304 USA

[5] Univ Leipzig, Leipzig, Germany

[6] Univ Colorado, Denver, CO 80202 USA

[7] Univ Turin, I-10124 Turin, Italy

[8] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[9] Baylor Univ, Dallas, TX USA

[10] Univ Utah, Salt Lake City, UT 84112 USA

[11] Oregon Hlth Sci Univ, Portland, OR 97201 USA

来源：

关键词：

D O I：

10.1016/j.bbmt.2003.12.107

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：26 / 26

页数：1